Z. Geng

发表

Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis

Qing Chen, Tom Boone, Raj Haldankar, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Moderately high consumption of ethanol suppresses bone resorption in ovariectomized but not in sexually intact adult female rats.

H. Malluche, P. Fanti, M. Monier‐Faugere, 1997, Alcoholism, clinical and experimental research.

Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease.

H. Malluche, P. Fanti, M. Monier‐Faugere, 2003, Kidney international.

Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin.

P. Kostenuik, M. Stolina, H. Ke, 2009, Bone.

Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis.

H. Malluche, M. Monier‐Faugere, Z. Geng, 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Parathyroid Hormone/Parathyroid Hormone‐Related Peptide Type 1 Receptor in Human Bone

N. Koszewski, H. Malluche, M. Monier‐Faugere, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

22-oxacalcitriol suppresses secondary hyperparathyroidism without inducing low bone turnover in dogs with renal failure.

H. Malluche, E. Slatopolsky, M. Monier‐Faugere, 1999, Kidney international.

The Phytoestrogen Genistein Reduces Bone Loss in Short-Term Ovariectomized Rats

P. Morris, H. Malluche, P. Fanti, 1998, Osteoporosis International.

Bone resorption and mRNA expression of IL-6 and IL-6 receptor in patients with renal osteodystrophy.

N. Koszewski, H. Malluche, M. Monier‐Faugere, 1996, Kidney international.

Infrequent Delivery of a Long‐Acting PTH‐Fc Fusion Protein Has Potent Anabolic Effects on Cortical and Cancellous Bone

Steven W. Martin, P. Kostenuik, S. Morony, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

RANKL Inhibition with Osteoprotegerin Increases Bone Strength by Improving Cortical and Trabecular bone Architecture in Ovariectomized Rats

P. Kostenuik, M. Stolina, H. Ke, 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

CD4+CD45RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin

P. Kostenuik, S. Morony, D. Lacey, 2004, Gut.

RANKL is a Marker and Mediator of Local and Systemic Bone Loss in Two Rat Models of Inflammatory Arthritis

P. Kostenuik, M. Stolina, G. Schett, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Receptor Activator of Nuclear Factor-κB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism

P. Kostenuik, S. Morony, D. Lacey, 2005, Calcified Tissue International.

Laboratory Investigations The Receptor Activator of Nuclear Factor-jB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism

P. Kostenuik, S. Morony, D. Lacey, 2006 .

The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.

P. Kostenuik, S. Morony, C. Capparelli, 2005, Endocrinology.

The RANKL Inhibitor Osteoprotegerin (OPG) Causes Greater Suppression of Bone Resorption and Hypercalcemia Compared to Bisphosphonates in Two Models of Humoral Hypercalcemia of Malignancy

P. Kostenuik, S. Morony, C. Capparelli, 2005 .

Gene therapy with human recombinant osteoprotegerin reverses established osteopenia in ovariectomized mice.

P. Kostenuik, S. Morony, B. Bolon, 2004, Bone.

INFLAMMATORY BOWEL DISEASE CD 4 + CD 45 RBHi T cell transfer induced colitis in mice is accompanied by osteopenia which is treatable with recombinant human osteoprotegerin

P. Kostenuik, S. Morony, D. Danilenko, 2004 .

Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients.

H. Malluche, M. Monier‐Faugere, Z. Geng, 2001, Kidney international.

Calcitonin Alters Bone Quality in Beagle Dogs

A. Boskey, N. Camacho, H. Malluche, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.

L. Donahue, T. Clemens, J. Fagin, 2000, Endocrinology.

Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.

P. Kostenuik, S. Morony, D. Lacey, 2006, Bone.

Bone morphogenetic protein receptor signaling is necessary for normal murine postnatal bone formation

S. Harris, Di Chen, G. Mundy, 2002, The Journal of cell biology.

Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral Properties

A. Boskey, F. Bauss, H. Malluche, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Calcitonin prevents bone loss but decreases osteoblastic activity in ovariohysterectomized beagle dogs

H. Malluche, M. Monier‐Faugere, Z. Geng, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Dickkopf‐1 regulates bone formation in young growing rodents and upon traumatic injury

P. Kostenuik, D. Lacey, T. Horan, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure.

F. Bauss, H. Malluche, M. Monier‐Faugere, 2000, Clinical nephrology.

Oncogenic Osteomalacia Associated with Metastatic Prostate Carcinoma: Case Report and Review of the Literature

C. McMurtry, R. Adler, H. Malluche, 1993, Journal of the American Geriatrics Society.